⚡ZurzAI.com⚡

Deep6.ai is a company leveraging artificial intelligence (AI) to streamline patient recruitment for clinical trials across healthcare organizations and life sciences. The company's platform is designed to match patients accurately and quickly to clinical trials by utilizing real-time electronic medical record (EMR) data, including both structured and unstructured data such as clinician notes and lab reports. This capability enables a more efficient trial recruitment process and helps researchers bring treatments to patients more rapidly.

Key Offerings and Features:

• AI and NLP Technology: The platform utilizes AI and Natural Language Processing (NLP) to sift through extensive patient records, identifying more patients who meet the criteria for clinical trials.
• Precision Patient Matching: Concept mapping represents patients as interconnected graphs, helping to generate holistic views of their profiles for better clinical insights and trial matching.
• Real-time Data Access: Enables stakeholders to query patient databases in real-time, assessing trial feasibility, protocol optimization, site selection, and potential patient recruitment across the entire healthcare network.
• Partnerships and Collaborative Ecosystem: Deep6.ai's Precision Research Ecosystem includes over 45 healthcare organizations and life sciences companies, working to improve patient-trial matching and streamline trial operations.

Solutions Offered:

1. Healthcare Organizations: Solutions include trial matching software to manage study feasibility requests, reduce staff time reviewing patient records, and facilitate faster clinical trials.
2. Life Sciences: Provides visibility into AI-matched patient data, supporting trial planning, recruitment, and real-world evidence (RWE) generation.
3. Site Selection: Optimizes site selection for trials by assessing the real-time availability of eligible patients, thereby making the site selection process more data-driven.
4. Recruitment Acceleration: Deep6.ai's platform aims to accelerate patient recruitment by providing AI-enhanced insights into patient data, facilitating efficient and targeted recruitment.
5. RWE Generation: The platform helps develop real-world data (RWD) sets that quicken the process of gathering and analyzing data, reducing the need for exhaustive manual data validation.

Notable Tools and Partnerships:

• Tools for Researchers and Physicians: Help with identifying and validating potential study participants in real-time, allowing more practitioners to embed research into their daily operations without compromising patient care.
• Magnolia Market Access Collaboration: Offers enhanced real-world evidence generation services by integrating comprehensive RWD with expert analytics.
• Clinical Trial Value Chain Management: Facilitates a streamlined trial design, patient recruitment, and enrollment monitoring, presenting real-time insights into trial performance metrics.

Engagement and Support:

• Deep6.ai's ecosystem supports the healthcare and life sciences communities by providing a secure and collaborative platform that is integrated across multiple health systems.
• Security Practices: The company is committed to maintaining high-security standards with features compliant with AWS, FHIR, HIPAA, HL7, and SOC 2 Type II.

Overall, Deep6.ai serves as a technology partner for advancing clinical trial processes, minimizing trial startup times, and enhancing the recruitment of diverse and representative study populations. Through robust AI-driven data analytics, the company looks to transform traditional clinical research practices, making them more efficient and effective.